Lexicon Pharmaceuticals (LXRX) Other Non-Current Assets (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Other Non-Current Assets data on file, last reported at $29.0 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 7780.43% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 7780.43% increase from a year earlier, with the FY2025 full-year figure at $368000.0, changed 0.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $29.0 million, up from $368000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for LXRX reached as high as $29.0 million in Q3 2025 and fell as low as $368000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $5.2 million across 5 years, with a median of $828000.0 in 2023.
• Across the five-year window, Other Non-Current Assets tumbled 89.6% in 2023 and surged 7780.43% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $412000.0 in 2022, then jumped by 100.97% to $828000.0 in 2023, then slumped by 55.56% to $368000.0 in 2024, then changed by 0.0% to $368000.0 in 2025, then jumped by 7780.43% to $29.0 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $29.0 million in Q1 2026, $368000.0 in Q4 2025, and $29.0 million in Q3 2025.